StockSignal
  • Screen for fundamentally interesting stocks
Sign in
Integer Holdings Corporation logo

Integer Holdings Corporation

ITGR · ARCX · Medical Devices · United States

Market Capitalization2.95B USD
Trailing P/E29.17 USD
52-Week Change-39.33 USD
Beta0.7380 USD

Integer Holdings Corporation is a leading provider of advanced medical device solutions, recognized as a major player within the global healthcare sector. Specializing in the design, development, and manufacturing of complex medical devices and components, Integer Holdings serves a wide array of markets, including cardiovascular, neuromodulation, orthopedic, and portable medical technology. The company is known for supplying sophisticated products such as cardiac rhythm management devices, neurostimulation systems, vascular and implantable components, as well as batteries supporting critical medical and healthcare equipment. Integer Holdings occupies an important position as a partner to medical device original equipment manufacturers (OEMs), supporting innovation and scaling in both established and emerging medical technology markets. With a substantial market capitalization and diversified revenue streams, Integer Holdings demonstrates strong financial fundamentals and resilience in the competitive healthcare and medical device manufacturing industry. Its expertise and comprehensive service offerings position it as a crucial link in the value chain, helping to advance patient care through next-generation technology and rigorous quality standards.

Industry

Medical Devices

Healthcare sector · United States

Stories

Structural patterns identified in Integer Holdings Corporation

No stories identified yet.

Key Metrics

Market Capitalization
2.95BUSD
NormalMar 22, 2026
Trailing P/E
29.17USD
NormalMar 22, 2026
Revenue (TTM)
1.85BUSD
NormalMar 22, 2026
Profit Margin
5.55%
NormalMar 22, 2026
Beta
0.7380USD
NormalMar 22, 2026
52-Week Change
-39.33USD
ExtremeMar 22, 2026

This company does not currently pay dividends.

Valuation9
Market Capitalization
2.95BUSD
NormalMar 22, 2026
Enterprise Value
4.20BUSD
NormalMar 22, 2026
Trailing P/E
29.17USD
NormalMar 22, 2026
Forward P/E
11.67USD
NormalMar 22, 2026
PEG Ratio
11.67USD
ExtremeMar 22, 2026
Price to Sales (TTM)
1.59USD
NormalMar 22, 2026
Price to Book (MRQ)
1.66USD
NormalMar 22, 2026
Enterprise to Revenue
2.27USD
NormalMar 22, 2026
Enterprise to EBITDA
11.14USD
NormalMar 22, 2026
Profitability & Growth17
Gross Margin
26.43%
NormalMar 22, 2026
Profit Margin
5.55%
NormalMar 22, 2026
Operating Margin
12.79%
NormalMar 22, 2026
Return on Assets (TTM)
0.0475USD
NormalMar 22, 2026
Return on Equity (TTM)
0.0611USD
NormalMar 22, 2026
Revenue (TTM)
1.85BUSD
NormalMar 22, 2026
Revenue per Share (TTM)
53.37USD
NormalMar 22, 2026
Quarterly Revenue Growth
0.0500USD
NormalMar 22, 2026
Gross Profit (TTM)
507.71MUSD
NormalMar 22, 2026
EBITDA
314.87MUSD
ExtremeMar 22, 2026
Net Income (TTM)
102.83MUSD
NormalMar 22, 2026
Quarterly Earnings Growth (YoY)
0.4860USD
NormalMar 22, 2026
Operating Cash Flow (TTM)
196.15MUSD
NormalMar 22, 2026
Levered Free Cash Flow (TTM)
76.88MUSD
NormalMar 22, 2026
Trailing Annual Dividend Rate
0.00USD
NormalMar 22, 2026
Trailing Annual Dividend Yield
0.00%
NormalMar 22, 2026
Payout Ratio
0.00USD
NormalMar 22, 2026
Financial Strength32
Shares Outstanding
34.35MShares
NormalMar 22, 2026
Float Shares
34.00MUSD
NormalMar 22, 2026
Shares Short
3.61MShares
NormalMar 22, 2026
Short Ratio
3.55USD
NormalMar 22, 2026
Short % of Shares Outstanding
0.1466USD
NormalMar 22, 2026
% Held by Insiders
0.0132USD
NormalMar 22, 2026
% Held by Institutions
1.11USD
AboveNormalMar 22, 2026
Total Cash (MRQ)
17.16MUSD
NormalMar 22, 2026
Total Cash per Share (MRQ)
0.4990USD
NormalMar 22, 2026
Total Debt (MRQ)
1.32BUSD
NormalMar 22, 2026
Total Debt to Equity (MRQ)
75.44USD
ExtremeMar 22, 2026
Current Ratio (MRQ)
3.32USD
AboveNormalMar 22, 2026
Book Value per Share (MRQ)
50.85USD
NormalMar 22, 2026
Total Assets
3.41B
NormalFY2025 · Dec 31, 2025
Total Current Assets
770.10M
NormalFY2025 · Dec 31, 2025
Total Liabilities
1.66B
NormalFY2025 · Dec 31, 2025
Total Non-current Assets
2.64B
NormalFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.43B
NormalFY2025 · Dec 31, 2025
Total Current Liabilities
232.04M
NormalFY2025 · Dec 31, 2025
Cash & Cash Equivalents
17.16M
NormalFY2025 · Dec 31, 2025
Accounts Receivable
346.08M
NormalFY2025 · Dec 31, 2025
Inventory
253.74M
NormalFY2025 · Dec 31, 2025
Accounts Payable
113.13M
NormalFY2025 · Dec 31, 2025
Short-term Debt
16.94M
NormalFY2025 · Dec 31, 2025
Deferred Revenue
5.21M
NormalFY2025 · Dec 31, 2025
Other Current Liabilities
13.88M
NormalFY2025 · Dec 31, 2025
Long-term Debt
1.30B
NormalFY2025 · Dec 31, 2025
Other Non-current Liabilities
19.91M
NormalFY2025 · Dec 31, 2025
Common Stock (Book)
35.00K
NormalFY2025 · Dec 31, 2025
Retained Earnings
994.05M
NormalFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.75B
NormalFY2025 · Dec 31, 2025
Treasury Stock
76.87M
ExtremeFY2025 · Dec 31, 2025
Market & Technical9
52-Week Low
62.00USD
NormalMar 22, 2026
52-Week High
127.56USD
NormalMar 22, 2026
52-Week Change
-39.33USD
ExtremeMar 22, 2026
Beta
0.7380USD
NormalMar 22, 2026
50-Day MA
85.29USD
NormalMar 22, 2026
200-Day MA
94.43USD
NormalMar 22, 2026
Avg 10-Day Volume
871.36KUSD
NormalMar 22, 2026
Avg 30-Day Volume
1.04MUSD
NormalMar 22, 2026
Diluted EPS (TTM)
2.89USD
NormalMar 22, 2026

Coordination

Placeholder CorpCoordination
Example HoldingsCoordination
Sample IncCoordination

Supply Chain

Medical Devices Supply Chain

The medical devices supply chain is shaped by three structural constraints that most manufacturing industries do not face: a regulatory classification cascade where risk level determines the years of validation required before a product can be sold, sterilization and biocompatibility requirements that restrict which materials and processes are permitted, and installed base dependency where hospitals commit to ecosystems that cannot be switched without replacing training, consumables, and data infrastructure.

StockSignal
  • Blog
  • Industries
  • Glossary
  • Stories
  • Coordinations
  • Constraint Archetypes
  • Legal

Contact

© 2026 StockSignal. All rights reserved.